Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Eur J Nutr ; 58(6): 2545-2560, 2019 Sep.
Article in English | MEDLINE | ID: mdl-30094646

ABSTRACT

PURPOSE: Dyslipidemia and impaired glucose metabolism are the main health issues of growing prevalence and significant high healthcare cost, requiring novel prevention and/or therapeutic approaches. Epidemiological and animal studies revealed that olive oil is an important dietary constituent, inducing normolipidemia. However, no studies have specifically investigated the polyphenol-rich water extract of olives (OLWPE), generated during olive oil production. METHODS: In the present work, we initially examined the effect of OLPWE on animals' metabolic parameters. Rats fed with a high-fat diet were treated with three different doses of OLPWE for 4 months. Additionally, bioavailability was explored. Afterwards, OLWPE's metabolic effect was explored in humans. Healthy volunteers consumed microencapsulated OLWPE for 4 weeks, in a food matrix [one portion (30 g) of a meat product]. RESULTS: High-fat-fed rats developed a metabolic dysfunction, with increased LDL and insulin levels and decreased HDL; this syndrome was significantly impaired when treated with OLWPE. Treated rats had increased total plasma antioxidant capacity, while several phenolic compounds were detected in their blood. These findings were also verified in humans that consumed OLWPE, daily, for 4 weeks. Interestingly, in individuals with elements of cardio-metabolic risk, OLWPE consumption resulted in reduced glucose, insulin, total cholesterol, LDL and oxLDL levels. CONCLUSIONS: Our data clearly show that OLWPE can improve glucose and lipid profile, indicating its possible use in the design of functional food and/or therapeutic interventions.


Subject(s)
Antioxidants/pharmacology , Diet, High-Fat/adverse effects , Olea , Plant Extracts/blood , Plant Extracts/pharmacology , Animals , Antioxidants/administration & dosage , Antioxidants/metabolism , Blood Glucose , Cholesterol/blood , Greece , Humans , Insulin/blood , Male , Models, Animal , Phenols/blood , Plant Extracts/administration & dosage , Rats , Rats, Sprague-Dawley , Water
2.
Gene Expr Patterns ; 7(4): 381-8, 2007 Feb.
Article in English | MEDLINE | ID: mdl-17251066

ABSTRACT

The Fras1/Frem gene family encodes for structurally similar, developmentally regulated extracellular matrix proteins. Mutations in Fras1, Frem1 and Frem2 have been identified in different classes of mouse bleb mutants, while defects in the human orthologs FRAS1 and FREM2 are causative for Fraser syndrome. The hallmark phenotypic feature of bleb mice is embryonic skin blistering due to dermal-epidermal detachment. The similarity of the phenotypic characteristics among the bleb mouse mutants, together with the fact that Fras1/Frem proteins are co-localized in embryonic epithelial basement membranes, suggest that they operate in a common pathway. Here, we report for the first time the immunofluorescence pattern of Frem3 and provide a comparative analysis of the spatiotemporal localization of all Fras1/Frem proteins during mouse embryonic development. We demonstrate their overall co-localization in embryonic epithelial basement membranes, with emphasis on areas of phenotypic interest such as eyelids, limbs, kidneys, lungs and organs of the gastrointestinal tract and the central nervous system. We further studied collagen VII, impairment of which produces dystrophic epidermolysis bullosa, a postnatal skin blistering disorder. We show that basement membrane levels of collagen VII rise at late embryonic life, concomitant with descending Fras1/Frem immunolabeling.


Subject(s)
Embryo, Mammalian/metabolism , Embryonic Development , Extracellular Matrix Proteins/analysis , Animals , Basement Membrane/embryology , Basement Membrane/metabolism , Collagen Type VII/genetics , Embryonic Development/genetics , Epithelium/embryology , Epithelium/metabolism , Extracellular Matrix Proteins/genetics , Mice , Mice, Mutant Strains , Phenotype , Skin/embryology , Skin/metabolism
3.
Biosens Bioelectron ; 19(4): 337-44, 2003 Dec 15.
Article in English | MEDLINE | ID: mdl-14615092

ABSTRACT

The work evaluated a series of approaches to optimise detection of polymerase chain reaction (PCR) amplified DNA samples by an optical sensor based on surface plasmon resonance (SPR) (BiacoreX). The optimised procedure was based on an asymmetric PCR amplification system to amplify predominantly one DNA strand, containing the sequence complementary to a specific probe. The study moved into two directions, aiming to improve the analytical performance of SPR detection in PCR amplified products. One approach concerned the application of new strategies at the level of PCR, i.e. asymmetric PCR to obtain ssDNA amplified fragments containing the target capable of hybridisation with the immobilised complementary probe. The other strategy focused on the post-PCR amplification stage. Optimised denaturing conditions were applied to both symmetrically and asymmetrically amplified fragments. The effective combination of the two strategies allowed a rapid and specific hybridisation reaction. The developed method was successfully applied in the detection of genetically modified organisms.


Subject(s)
Biosensing Techniques/methods , DNA Probes/chemistry , DNA/analysis , DNA/chemistry , Polymerase Chain Reaction/methods , Surface Plasmon Resonance/methods , DNA/genetics , DNA Probes/chemical synthesis , Nucleic Acid Amplification Techniques/methods , Nucleic Acid Denaturation , Optics and Photonics , Reproducibility of Results , Sensitivity and Specificity
SELECTION OF CITATIONS
SEARCH DETAIL
...